BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 33917181)

  • 1. Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response.
    Valenti F; Falcone I; Ungania S; Desiderio F; Giacomini P; Bazzichetto C; Conciatori F; Gallo E; Cognetti F; Ciliberto G; Morrone A; Guerrisi A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omics sciences and precision medicine in melanoma.
    Medori MC; Donato K; Dhuli K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Gisondi P; Bellinato F; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):29-36. PubMed ID: 37994746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omics sciences and precision medicine in glioblastoma.
    Micheletti C; Bonetti G; Madeo G; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Manganotti P; Caruso P; Bernini A; Fulcheri E; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):77-84. PubMed ID: 37994751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.
    Joshi MS; Montgomery KA; Giannone PJ; Bauer JA; Hanna MH
    Pediatr Res; 2017 Jan; 81(1-2):271-276. PubMed ID: 27723726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
    Pecak M; Korošec P; Kunej T
    OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention.
    Aleksandrova K; Egea Rodrigues C; Floegel A; Ahrens W
    Curr Obes Rep; 2020 Sep; 9(3):219-230. PubMed ID: 32594318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What did we learn from multiple omics studies in asthma?
    Ivanova O; Richards LB; Vijverberg SJ; Neerincx AH; Sinha A; Sterk PJ; Maitland-van der Zee AH
    Allergy; 2019 Nov; 74(11):2129-2145. PubMed ID: 31004501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods.
    Kuang Z; Kong M; Yan N; Ma X; Wu M; Li J
    Curr Treat Options Oncol; 2024 May; 25(5):679-701. PubMed ID: 38676836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not your average joint: Towards precision medicine in psoriatic arthritis.
    Castillo R; Scher JU
    Clin Immunol; 2020 Aug; 217():108470. PubMed ID: 32473975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Power of proteomics and progress in precision medicine - 13th central and eastern European proteomic conference (CEEPC), Ustroń, Poland.
    Gadher SJ; Widlak P; Kovarova H
    Expert Rev Proteomics; 2020 May; 17(5):335-340. PubMed ID: 32510255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biomarkers in melanoma: detection and discovery.
    Lim SY; Lee JH; Diefenbach RJ; Kefford RF; Rizos H
    Mol Cancer; 2018 Jan; 17(1):8. PubMed ID: 29343260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "-OMICS" facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers.
    Donnelly D; Aung PP; Jour G
    Semin Cancer Biol; 2019 Dec; 59():165-174. PubMed ID: 31295564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omics for the future in asthma.
    Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
    Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.
    Ascierto PA; Agarwala SS; Ciliberto G; Demaria S; Dummer R; Duong CPM; Ferrone S; Formenti SC; Garbe C; Halaban R; Khleif S; Luke JJ; Mir LM; Overwijk WW; Postow M; Puzanov I; Sondel P; Taube JM; Thor Straten P; Stroncek DF; Wargo JA; Zarour H; Thurin M
    J Transl Med; 2017 Nov; 15(1):236. PubMed ID: 29145885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders.
    Singh S; Sarma DK; Verma V; Nagpal R; Kumar M
    Biochem Biophys Res Commun; 2023 Nov; 682():1-20. PubMed ID: 37788525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omics sciences and precision medicine in thyroid cancer.
    Dhuli K; Medori MC; Donato K; Donato K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):11-20. PubMed ID: 37994744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.